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Abstract: BACKGROUND:: Intraoperative high inspired oxygen fraction (FIO2) is thought to reduce
the incidence of surgical site infection (SSI) and postoperative nausea and vomiting, and to promote
postoperative atelectasis. METHODS:: The authors searched for randomized trials (till September 2012)
comparing intraoperative high with normal FIO2 in adults undergoing surgery with general anesthesia
and reporting on SSI, nausea or vomiting, or pulmonary outcomes. RESULTS:: The authors included 22
trials (7,001 patients) published in 26 reports. High FIO2 ranged from 80 to 100% (median, 80%); normal
FIO2 ranged from 30 to 40% (median, 30%). In nine trials (5,103 patients, most received prophylactic
antibiotics), the incidence of SSI decreased from 14.1% with normal FIO2 to 11.4% with high FIO2;
risk ratio, 0.77 (95% CI, 0.59-1.00). After colorectal surgery, the incidence of SSI decreased from 19.3 to
15.2%; risk ratio, 0.78 (95% CI, 0.60-1.02). In 11 trials (2,293 patients), the incidence of nausea decreased
from 24.8% with normal FIO2 to 19.5% with high FIO2; risk ratio, 0.79 (95% CI, 0.66-0.93). In patients
receiving inhalational anesthetics without prophylactic antiemetics, high FIO2 provided a significant
protective effect against both nausea and vomiting. Nine trials (3,698 patients) reported on pulmonary
outcomes. The risk of atelectasis was not increased with high FIO2. CONCLUSIONS:: Intraoperative
high FIO2 further decreases the risk of SSI in surgical patients receiving prophylactic antibiotics, has a
weak beneficial effect on nausea, and does not increase the risk of postoperative atelectasis.
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Summary	  Statement	  
Intra-­‐operative	  high	  FIO2	  decreases	  the	  risk	  of	  surgical	  site	  infection	  in	  surgical	  patients	  
receiving	  prophylactic	  antibiotics,	  has	  a	  weak	  beneficial	  effect	  on	  nausea,	  and	  does	  not	  
increase	  the	  risk	  of	  postoperative	  atelectasis.	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Abstract	  
BACKGROUND:	  Intra-­‐operative	  high	  inspired	  oxygen	  fraction	  (FIO2)	  is	  thought	  to	  reduce	  the	  
incidence	  of	  surgical	  site	  infection	  and	  postoperative	  nausea	  and	  vomiting,	  and	  to	  promote	  
postoperative	  atelectasis.	  	  
METHODS:	  We	  searched	  for	  randomized	  trials	  (to	  09.2012)	  comparing	  intra-­‐operative	  high	  
with	  normal	  FIO2	  in	  adults	  undergoing	  surgery	  under	  general	  anesthesia	  and	  reporting	  on	  
surgical	  site	  infection,	  nausea	  or	  vomiting,	  or	  pulmonary	  outcomes.	  
RESULTS:	  We	  included	  22	  trials	  (7,001	  patients)	  published	  in	  26	  reports.	  High	  FIO2	  ranged	  
from	  80%	  to	  100%	  (median,	  80%);	  normal	  FIO2	  ranged	  from	  30%	  to	  40%	  (median,	  30%).	  In	  9	  
trials	  (5,103	  patients,	  most	  received	  prophylactic	  antibiotics),	  the	  incidence	  of	  surgical	  site	  
infection	  decreased	  from	  14.1%	  with	  normal	  FIO2	  to	  11.4%	  with	  high	  FIO2;	  risk	  ratio	  0.77	  
(95%	  confidence	  interval,	  0.59	  to	  1.00).	  After	  colorectal	  surgery,	  the	  incidence	  of	  surgical	  site	  
infection	  decreased	  from	  19.3%	  to	  15.2%;	  risk	  ratio	  0.78	  (95%	  confidence	  interval,	  0.60	  to	  
1.02).	  In	  11	  trials	  (2,293	  patients),	  the	  incidence	  of	  nausea	  decreased	  from	  24.8%	  with	  
normal	  FIO2	  to	  19.5%	  with	  high	  FIO2;	  risk	  ratio	  0.79	  (95%	  confidence	  interval,	  0.66	  to	  0.93).	  
In	  patients	  receiving	  inhalational	  anesthetics	  without	  prophylactic	  anti-­‐emetics,	  high	  FIO2	  
provided	  a	  significant	  protective	  effect	  against	  both	  nausea	  and	  vomiting.	  Nine	  trials	  (3,698	  
patients)	  reported	  on	  pulmonary	  outcomes.	  The	  risk	  of	  atelectasis	  was	  not	  increased	  with	  
high	  FIO2.	  
CONCLUSIONS:	  Intra-­‐operative	  high	  FIO2	  further	  decreases	  the	  risk	  of	  surgical	  site	  infection	  
in	  surgical	  patients	  receiving	  prophylactic	  antibiotics,	  has	  a	  weak	  beneficial	  effect	  on	  nausea,	  
and	  does	  not	  increase	  the	  risk	  of	  postoperative	  atelectasis.	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Introduction	  
It	  has	  been	  claimed	  that	  patients	  undergoing	  surgery	  under	  general	  anesthesia	  were	  
benefiting	  from	  a	  higher	  than	  normal	  inspired	  oxygen	  fraction	  (FIO2).
1,2	  Some	  authors	  have	  
suggested	  that	  a	  high	  FIO2	  was	  a	  simple,	  inexpensive,	  and	  low-­‐risk	  intervention	  and	  that	  the	  
broader	  use	  of	  this	  technique	  should	  be	  encouraged	  in	  patients	  undergoing	  major	  abdominal	  
procedures.3	  Randomized	  trials	  have	  reported	  on	  a	  reduced	  risk	  of	  surgical	  site	  infection	  
(SSI)	  in	  patients	  who	  were	  ventilated	  with	  80%	  FIO2	  during	  surgery.
4,5	  It	  was	  also	  shown	  that	  
patients	  who	  were	  ventilated	  with	  high	  FIO2	  intra-­‐operatively	  had	  a	  reduced	  incidence	  of	  
postoperative	  nausea	  and	  vomiting	  (PONV).6,7	  
Other	  authors	  were	  more	  cautious.8,9	  Skepticism	  has	  been	  partly	  related	  to	  the	  fact	  that	  high	  
FIO2	  may	  have	  deleterious	  effects	  in	  the	  airways.	  One	  hundred	  percent	  oxygen	  at	  induction	  
or	  at	  the	  end	  of	  general	  anesthesia	  has	  been	  suggested	  to	  promote	  atelectasis	  over	  a	  few	  
minutes,10-­‐12	  and	  to	  cause	  alteration	  in	  gas	  exchange.13	  	  
Both	  SSI	  and	  PONV	  remain	  a	  crucial	  topic	  for	  anesthetists	  and	  surgeons,	  as	  they	  represent	  a	  
significant	  clinical	  and	  economical	  burden;	  SSI	  may	  lead	  to	  prolonged	  length	  of	  stay	  and	  
increased	  hospital	  costs,14-­‐16	  while	  PONV	  symptoms	  are	  among	  the	  most	  frequent	  adverse	  
effects	  of	  anesthesia	  and	  surgery	  and	  they	  are	  also	  associated	  with	  incremental	  costs.17-­‐19	  
Meta-­‐analyses	  of	  clinical	  trials	  addressing	  the	  potential	  benefit	  of	  high	  FIO2	  in	  surgical	  
patients	  have	  reported	  on	  conflicting	  results.20-­‐26	  A	  number	  of	  further	  relevant	  clinical	  trials	  
studying	  these	  issues	  have	  been	  published	  recently.27-­‐30	  The	  aim	  of	  our	  study	  was	  to	  update	  
previously	  published	  meta-­‐analyses,	  and	  to	  provide	  a	  comprehensive	  quantitative	  summary	  
of	  the	  most	  important,	  potentially	  beneficial	  (decrease	  in	  the	  risk	  of	  SSI	  or	  PONV)	  and	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harmful	  (increase	  in	  the	  risk	  of	  pulmonary	  complications)	  effects	  of	  intra-­‐operative	  high	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Materials	  and	  Methods	  
We	  followed	  the	  PRISMA	  guidelines	  for	  the	  reporting	  of	  meta-­‐analyses	  of	  randomized	  
controlled	  trials.31	  
Eligibility	  Criteria	  
We	  searched	  for	  published	  full	  reports	  of	  randomized	  comparisons	  of	  intra-­‐operative	  high	  
FIO2	  (experimental	  intervention)	  versus	  normal	  (i.e.	  “low”)	  FIO2	  (control	  intervention).	  A	  high	  
FIO2	  was	  defined	  as	  a	  FIO2	  ≥50%	  and	  a	  normal	  FIO2	  as	  a	  FIO2	  <50%.	  	  
In	  trials	  with	  a	  limited	  high-­‐to-­‐normal	  FIO2	  ratio,	  the	  difference	  in	  oxygen	  regimens	  may	  be	  
too	  small	  and	  consequently	  the	  high	  FIO2	  regimen	  may	  not	  have	  the	  scope	  to	  show	  efficacy.	  
Also,	  such	  trials	  may	  produce	  positive	  results	  by	  random	  chance.	  Consequently,	  there	  was	  an	  
arbitrary	  pre	  hoc	  decision	  to	  include	  only	  studies	  where	  the	  normal	  FIO2	  value	  was	  less	  than,	  
or	  equal	  to,	  half	  of	  the	  high	  FIO2	  value.	  
We	  considered	  studies	  that	  were	  performed	  in	  adult	  patients	  (≥	  18	  years)	  undergoing	  any	  
surgical	  procedure	  under	  general	  anesthesia	  and	  that	  reported	  on	  at	  least	  one	  of	  three	  
outcomes:	  (1)	  SSI;	  (2)	  PONV;	  (3)	  intra-­‐	  or	  postoperative	  pulmonary	  outcomes.	  	  
Data	  from	  animal	  studies	  or	  abstracts	  were	  not	  considered.	  Reports	  of	  patients	  undergoing	  
surgery	  with	  regional	  anesthesia,	  patients	  undergoing	  one-­‐lung	  surgery,	  or	  patients	  receiving	  
high	  FIO2	  in	  other	  settings	  than	  general	  anesthesia	  for	  surgery	  as,	  for	  instance,	  patients	  
ventilated	  in	  the	  intensive	  care	  or	  in	  the	  pre-­‐hospital	  setting,	  were	  excluded.	  Studies	  where	  
supplemental	  oxygen	  was	  administered	  only	  postoperatively,	  or	  for	  a	  restricted	  time	  during	  
anesthesia	  (for	  instance,	  at	  induction	  or	  during	  a	  short	  period	  before	  extubation),	  were	  not	  
considered.	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Information	  Sources	  
We	  performed	  a	  variety	  of	  high	  sensitivity	  and	  low	  specificity	  searches	  for	  relevant	  reports	  in	  
the	  Medline,	  Embase,	  and	  Central	  databases.	  Key	  words	  (“oxygen”,	  “supplemental”,	  
“anesthesia”)	  were	  combined	  using	  the	  Boolean	  meanings	  of	  “and”	  and	  “or”.	  The	  last	  
electronic	  search	  was	  in	  September	  2012.	  Bibliographies	  of	  retrieved	  articles	  were	  searched	  
for	  additional	  references.	  We	  applied	  no	  restriction	  on	  language.	  	  
Study	  Selection	  
Retrieved	  articles	  were	  reviewed	  for	  inclusion	  by	  one	  author	  (FH)	  and	  criteria	  for	  inclusion	  
were	  independently	  checked	  by	  another	  author	  (CL).	  Queries	  were	  resolved	  through	  
discussion	  with	  a	  third	  author	  (MRT).	  
Risk	  of	  Biases	  in	  Individual	  Studies	  
Quality	  of	  data	  reporting	  was	  assessed	  by	  one	  author	  (FH)	  and	  was	  independently	  checked	  
by	  another	  (CL),	  using	  a	  modified	  4-­‐items,	  7-­‐points	  Oxford	  scale	  taking	  into	  account	  method	  
of	  randomization,	  concealment	  of	  treatment	  allocation,	  degree	  of	  blinding,	  and	  reporting	  of	  
drop-­‐outs,	  as	  previously	  described.32	  Consensus	  was	  reached	  by	  discussion	  with	  a	  third	  
author	  (MRT).	  
Since	  potential	  confounding	  factors	  (for	  instance,	  carrier	  gas	  or	  fluid	  regimen)	  may	  directly	  
affect	  the	  occurrence	  of	  SSI,	  regardless	  of	  the	  FIO2,
1,33,34	  we	  retrieved	  such	  information	  from	  
each	  study.	  For	  the	  analysis	  of	  SSI	  data,	  nitrous	  oxide	  was	  not	  regarded	  as	  a	  potential	  
confounding	  factor.35	  However,	  for	  the	  analyses	  of	  PONV	  data,	  we	  excluded	  data	  from	  
studies	  that	  were	  using	  nitrous	  oxide	  as	  a	  carrier	  gas,	  since	  nitrous	  oxide	  has	  emetogenic	  
properties.36	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Data	  Extraction	  Process	  
One	  author	  (FH)	  extracted	  all	  relevant	  information	  from	  original	  reports.	  Another	  author	  (CL)	  
independently	  checked	  all	  extracted	  data.	  Discrepancies	  were	  resolved	  by	  discussion	  with	  a	  
third	  author	  (MRT).	  
Data	  items	  
Definitions	  of	  SSI	  were	  taken	  as	  reported	  in	  the	  original	  reports.	  	  
Three	  distinct	  PONV	  outcomes	  were	  analyzed:37	  nausea,	  vomiting	  (including	  retching),	  and	  a	  
composite	  endpoint	  (i.e.	  nausea	  and/or	  vomiting/retching).	  Cumulative	  incidences	  of	  these	  
outcomes	  were	  extracted	  for	  two	  time	  periods,	  an	  early	  period	  (0	  to	  6	  hours),	  and	  a	  late	  
period	  (0	  to	  24	  hours).	  	  
Pulmonary	  complications	  were	  defined	  as	  any	  adverse	  event	  occurring	  intra-­‐	  or	  
postoperatively	  and	  affecting	  the	  lower	  respiratory	  tract	  and/or	  interfering	  with	  normal	  test	  
values	  related	  to	  lung	  integrity	  (blood	  gases,	  spirometry,	  chest	  imagery,	  arterial	  oxygen	  
saturation	  measure	  through	  pulse	  oximetry,	  postoperative	  oxygen	  requirements).	  
Synthesis	  of	  Results	  
For	  dichotomous	  data,	  we	  calculated	  risk	  ratios	  (RR)	  with	  95%	  confidence	  intervals	  (CI).	  
When	  the	  95%	  CI	  around	  the	  RR	  point	  estimate	  did	  not	  include	  1,	  the	  difference	  between	  
experimental	  and	  control	  group	  was	  considered	  statistically	  significant.	  	  
For	  continuous	  data,	  weighted	  mean	  differences	  with	  95%	  CI	  were	  calculated.	  	  
We	  performed	  formal	  heterogeneity	  testing.	  When	  the	  data	  were	  homogenous	  (P≥0.1),	  we	  
used	  a	  fixed	  effect	  model	  to	  combine	  data	  from	  independent	  trials.	  When	  the	  data	  were	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heterogeneous,	  we	  searched	  for	  sources	  of	  heterogeneity.	  For	  example,	  if	  one	  study	  showed	  
results	  that	  were	  completely	  out	  of	  range	  of	  the	  others,	  we	  searched	  for	  likely	  reasons	  
explaining	  the	  difference	  and	  performed	  a	  sensitivity	  analysis	  excluding	  that	  study,	  when	  
deemed	  appropriate.	  When	  no	  source	  could	  be	  identified	  that	  explained	  the	  heterogeneity,	  
we	  combined	  the	  data	  using	  a	  random	  effects	  model.	  Sources	  of	  heterogeneity	  to	  be	  sought	  
were	  not	  pre-­‐specified.	  	  
Analyses	  were	  performed	  using	  STATA	  11	  (Version	  11,	  STATA	  Corp,	  College	  Station,	  TX),	  
RevMan	  (Computer	  Program,	  version	  5.1.6,	  Copenhagen:	  The	  Nordic	  Cochrane	  Centre,	  The	  
Cochrane	  Collaboration,	  Denmark),	  and	  Microsoft®	  Excel®	  12.2.3.	  for	  Mac	  (Microsoft	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Results	  
Study	  Selection	  
We	  retrieved	  204	  articles	  (FIGURE	  1).	  Of	  45	  potentially	  relevant	  randomized	  trials,	  19	  were	  
excluded	  after	  more	  thorough	  examination.	  In	  4,	  the	  inspired	  oxygen	  fraction	  in	  control	  
patients	  was	  >50%.38-­‐41	  Data	  of	  6	  studies	  could	  not	  be	  extracted	  for	  meta-­‐analysis:	  4	  
reported	  measures	  of	  associations42-­‐45	  and	  2	  provided	  results	  in	  graphical	  format	  only.46,47	  
Three	  included	  data	  from	  children.48-­‐50	  In	  3	  trials,	  the	  oxygen	  fraction	  administrated	  in	  the	  
control	  group	  was	  more	  than	  half	  of	  that	  administrated	  in	  the	  experimental	  group;	  2	  of	  
those	  compared	  50%	  with	  30%,51,52	  and	  one	  compared	  60%	  with	  45%.53	  One	  trial	  was	  using	  
nitrous	  oxide	  as	  a	  carrier	  gas	  and	  reported	  on	  PONV	  outcomes	  only.54	  Finally,	  2	  studies	  were	  
recently	  retracted	  due	  to	  ethical	  concerns.‡§	  
We	  eventually	  included	  data	  from	  22	  randomized	  trials	  (7,001	  patients)	  that	  were	  reported	  
in	  26	  articles.4-­‐7,27-­‐30,55-­‐72	  Seven	  reports	  with	  additional	  data	  from	  900	  patients	  have	  not	  been	  
considered	  for	  any	  previously	  published	  meta-­‐analyses.27-­‐30,61,69,70	  Two	  articles	  reporting	  on	  
pulmonary	  outcomes56	  and	  PONV,7	  respectively,	  were	  subgroup	  analyses	  of	  a	  multicenter	  
study	  that	  reported	  on	  SSI.5	  Results	  of	  another	  multicenter	  study	  reporting	  on	  SSI	  and	  
pulmonary	  outcomes63	  were	  reported	  in	  2	  further	  articles;	  one	  concentrated	  on	  pulmonary	  
outcomes	  in	  obese	  patients,70	  the	  other	  on	  pulmonary	  outcomes	  in	  patients	  scheduled	  for	  
laparotomy	  for	  ovarian	  cancer.69	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
‡Ochmann	  C,	  Tuschy	  B,	  Beschmann	  R,	  Hamm	  F,	  Rohm	  KD,	  Piper	  SN:	  Supplemental	  oxygen	  reduces	  serotonin	  
levels	  in	  plasma	  and	  platelets	  during	  colorectal	  surgery	  and	  reduces	  postoperative	  nausea	  and	  vomiting.	  Eur	  J	  
Anaesthesiol	  2010;	  27:	  1036-­‐43	  
§Fujii	  Y,	  Itakura	  M:	  Supplemental	  intraoperative	  oxygen	  prevents	  postoperative	  nausea	  and	  vomiting	  inpatients	  
undergoing	  gynecological	  laparoscopic	  surgery.	  Anesthesia	  and	  Resuscitation	  2008;	  44:	  47-­‐50	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Study	  Characteristics	  
Included	  reports	  were	  published	  between	  2000	  and	  2012	  (tables	  1-­‐3).	  The	  median	  quality	  
score	  was	  5.5	  (range,	  2	  to	  7).	  In	  experimental	  groups,	  intra-­‐operative	  FIO2	  ranged	  from	  80%	  
to	  100%	  (median,	  80%),	  in	  controls	  ranged	  from	  30%	  to	  40%	  (median,	  30%).	  	  
Synthesis	  of	  Results	  
Surgical	  Site	  Infection	  
Nine	  studies	  (5,103	  patients)	  reported	  on	  the	  incidence	  of	  SSI	  (table	  1).4,5,28,30,58,62-­‐64,66	  Six	  
studies	  considered	  SSI	  as	  an	  infection	  occurring	  within	  14	  days	  postoperatively,	  and	  2	  within	  
30	  days;30,62	  one	  trial	  did	  not	  mention	  the	  duration	  of	  follow-­‐up.28	  Seven	  studies	  used	  a	  
standardized	  method	  for	  SSI	  assessment:	  3	  considered	  the	  ASEPSIS	  scoring	  system,4,5,58	  2	  
used	  the	  definition	  of	  the	  Centers	  for	  Disease	  Control	  and	  Prevention,30,63	  and	  2	  considered	  a	  
prospectively	  determined	  scoring	  system.28,66	  In	  all	  trials	  except	  one,30	  90	  to	  100%	  of	  
patients	  received	  prophylactic	  antibiotics.	  
Surgeries	  were	  colorectal,	  appendectomy,	  abdominal,	  and	  gynecologic.	  Two	  trials	  reported	  
on	  abdominal	  and	  non-­‐abdominal	  procedures.30,64	  The	  baseline	  risk	  of	  SSI,	  i.e.	  the	  incidence	  
of	  SSI	  in	  patients	  receiving	  normal	  FIO2,	  ranged	  from	  7%
30	  to	  27%.28	  When	  data	  were	  
combined,	  there	  was	  an	  average	  incidence	  of	  14.1%	  with	  normal	  FIO2	  and	  of	  11.4%	  with	  high	  
FIO2;	  RR	  0.77	  (95%CI,	  0.59	  to	  1.00)	  (FIGURE	  2A).	  Because	  data	  were	  heterogeneous	  
(Phetero=0.03),	  we	  used	  a	  random	  effects	  model.	  	  
Since	  it	  has	  been	  argued	  that	  patients	  undergoing	  colorectal	  surgery	  may	  particularly	  profit	  
from	  a	  high	  FIO2	  regimen,
24,26	  we	  performed	  a	  subgroup	  analysis	  including	  all	  patients	  
undergoing	  colorectal	  surgery.	  Four	  trials	  were	  performed	  exclusively	  in	  patients	  undergoing	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colorectal	  surgery,4,5,28,62	  and	  from	  4,	  data	  from	  patients	  undergoing	  colorectal	  surgery	  could	  
be	  extracted.30,63,64,66	  When	  all	  colorectal	  surgery	  data	  were	  combined	  (n=1,977),	  there	  was	  
an	  average	  incidence	  of	  SSI	  of	  19.3%	  with	  normal	  FIO2	  and	  of	  15.2%	  with	  high	  FIO2;	  RR	  0.78	  
(95%CI,	  0.60	  to	  1.02)	  (FIGURE	  2B).	  The	  data	  were	  homogenous	  (Phetero=0.19).	  We	  additionally	  
performed	  a	  meta-­‐analysis	  using	  a	  fixed	  effect	  model;	  the	  RR	  was	  0.80	  (95%	  CI,	  0.66	  to	  0.97).	  
Postoperative	  Nausea	  and	  Vomiting	  
Eleven	  trials	  (2,293	  patients)	  reported	  dichotomous	  data	  on	  presence	  or	  absence	  of	  nausea	  
or	  vomiting	  (table	  2).6,7,27,29,30,57,59,65,67,68,71	  	  
When	  combining	  all	  data,	  only	  prevention	  of	  late	  nausea	  showed	  statistical	  significance	  in	  
favor	  of	  high	  FIO2	  (FIGURE	  3A).	  With	  normal	  FIO2,	  the	  average	  incidence	  of	  late	  nausea	  was	  
24.8%,	  with	  high	  FIO2	  was	  19.5%;	  RR	  0.79	  (95%CI,	  0.66	  to	  0.93).	  
Since	  propofol	  and	  prophylactic	  anti-­‐emetics	  reduce	  the	  underlying	  risk	  of	  PONV,	  we	  
performed	  a	  sensitivity	  analysis	  including	  exclusively	  data	  from	  patients	  who	  received	  an	  
inhalational	  anesthetic	  without	  prophylactic	  anti-­‐emetics.6,7,27,29,57,59,67,68	  As	  expected,	  
incidences	  of	  PONV	  outcomes	  in	  patients	  receiving	  normal	  FIO2	  were	  increased	  (FIGURE	  3B).	  
With	  normal	  FIO2,	  the	  average	  incidence	  of	  late	  nausea	  was	  33.7%,	  with	  high	  FIO2	  was	  
29.3%;	  RR	  0.75	  (95%CI,	  0.62	  to	  0.90).	  With	  normal	  FIO2,	  the	  average	  incidence	  of	  late	  
vomiting	  was	  26.2%,	  with	  high	  FIO2	  was	  19.2%;	  RR	  0.72	  (95%CI,	  0.56	  to	  0.92).	  When	  
analyzing	  the	  composite	  endpoint	  PONV,	  no	  statistical	  significance	  was	  reached.	  
Pulmonary	  Outcomes	  
Nine	  trials	  (3,698	  patients)	  reported	  on	  pulmonary	  outcomes	  (table	  3).55,56,60,61,63,64,69,70,72	  Six	  
articles	  reported	  on	  atelectasis	  using	  chest	  radiographs	  and/or	  thoracic	  computed	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tomography-­‐scans	  for	  diagnosis	  (table	  4);	  however,	  2	  of	  those69,70	  were	  subgroup	  analyses	  
reporting	  on	  the	  same	  outcomes	  as	  the	  original	  larger	  study.63	  Thus,	  data	  from	  4	  trials,	  2	  
small56,60	  and	  2	  large,63,64	  could	  be	  combined	  (FIGURE	  4).	  The	  average	  incidence	  of	  
atelectasis	  with	  high	  FIO2	  was	  8.3%,	  with	  normal	  FIO2	  was	  10.6%;	  RR	  0.93	  (95%CI,	  0.59	  to	  
1.46).	  	  
Three	  small	  trials	  reported	  on	  peri-­‐operative	  blood	  gas	  analyses	  (table	  4).55,60,69	  In	  one,55	  
there	  was	  evidence	  of	  a	  statistically	  significant	  worsening	  of	  the	  intra-­‐operative	  PaO2/FIO2	  
ratio	  in	  patients	  receiving	  100%	  FIO2	  (use	  of	  positive	  end-­‐expiratory	  pressure	  and	  
postoperative	  PaO2/FIO2	  ratio	  were	  not	  reported).	  The	  2	  other	  studies	  failed	  to	  show	  any	  
detrimental	  effect	  on	  the	  postoperative	  PaO2/FIO2	  ratio	  with	  supplemental	  oxygen,
60,69	  
despite	  the	  use	  of	  100%	  oxygen	  and	  no	  positive	  end-­‐expiratory	  pressure	  in	  one	  trial.60	  	  
Three	  small	  studies	  reported	  on	  lung	  function	  (table	  4).56,69,72	  In	  2,	  spirometry	  values	  were	  
not	  different	  in	  patients	  receiving	  high	  or	  normal	  FIO2.
56,69	  The	  third,	  including	  142	  
moderately	  obese	  patients,	  reported	  on	  a	  variety	  of	  postoperative	  spirometric	  values	  that	  
were	  significantly	  worsened	  with	  high	  oxygen	  fraction.72	  Specifically,	  there	  was	  a	  linear	  
decrease	  in	  postoperative	  lung	  function	  with	  increasing	  body	  mass	  index	  in	  the	  high-­‐oxygen	  
group.	  
Two	  studies	  reported	  on	  postoperative	  SpO2	  values.
69,72	  Both	  failed	  to	  show	  a	  significant	  
decrease	  in	  the	  24h-­‐postoperative	  SpO2	  in	  patients	  exposed	  to	  high	  FIO2.	  
Finally,	  one	  trial	  showed	  no	  difference	  in	  postoperative	  oxygen	  requirements	  among	  
patients	  ventilated	  with	  a	  high	  or	  normal	  FIO2.
61	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Discussion	  	  
We	  performed	  a	  systematic	  review	  and	  meta-­‐analysis	  of	  clinical	  trials	  testing	  the	  role	  of	  high	  
inspired	  oxygen	  fraction	  in	  patients	  undergoing	  surgery	  under	  general	  anesthesia.	  We	  
studied	  outcomes	  that	  are	  relevant	  in	  this	  context,	  i.e.	  SSI,	  PONV,	  and	  pulmonary	  
complications.	  We	  analyzed	  data	  from	  22	  randomized	  trials	  (including	  7,001	  patients)	  that	  
were	  reported	  in	  26	  articles.	  	  
When	  combining	  data	  of	  all	  eligible	  patients,	  regardless	  of	  the	  type	  of	  surgery,	  the	  risk	  of	  SSI	  
decreased	  by	  23%	  with	  high	  FIO2	  (RR	  0.77),	  and	  the	  difference	  was	  borderline	  statistically	  
significant.	  When	  selecting	  patients	  undergoing	  colorectal	  surgery,	  the	  RR	  point	  estimate	  
was	  similar,	  and,	  depending	  on	  the	  statistical	  model	  that	  was	  used,	  the	  95%	  confidence	  
interval	  included	  (random	  effects	  model)	  or	  excluded	  (fixed	  effect	  model)	  equality.	  Previous	  
meta-­‐analyses	  have	  yielded	  conflicting	  results	  on	  the	  potential	  benefit	  of	  high	  FIO2	  on	  SSI.	  
Three	  reported	  on	  a	  significant	  reduction	  in	  the	  incidence	  of	  SSI.20,22,24	  A	  fourth	  analysis,	  
similar	  to	  ours,	  reported	  on	  a	  statistically	  significant	  result	  in	  favor	  of	  high	  FIO2	  when	  a	  fixed	  
effect	  model	  was	  used	  but	  failed	  to	  show	  any	  benefit	  with	  a	  random	  effects	  model.21	  Finally,	  
a	  fifth	  analysis	  reported	  on	  a	  protective	  effect	  with	  high	  FIO2	  in	  patients	  undergoing	  
colorectal	  surgery	  only,	  but	  not	  in	  patients	  undergoing	  other	  abdominal	  surgeries.26	  Many	  
authors	  have	  considered	  that	  subgroup	  as	  the	  most	  likely	  to	  profit	  from	  a	  high	  FIO2.
24,26	  The	  
question	  then	  is,	  whether	  this	  benefit	  is	  of	  clinical	  relevance.	  Although	  the	  degree	  of	  anti-­‐
infective	  efficacy	  of	  high	  FIO2	  seems	  weak	  and	  perhaps	  disappointing,	  it	  appears	  to	  be	  similar	  
to	  conventional	  antibiotic	  prophylaxis	  in	  many	  surgical	  settings.73	  Also,	  as	  most	  patients	  in	  
these	  trials	  had	  received	  prophylactic	  antibiotics,	  we	  may	  conclude	  on	  the	  efficacy	  of	  high	  
FIO2	  as	  a	  supplemental	  anti-­‐infection	  strategy	  only;	  the	  efficacy	  of	  high	  FIO2	  alone	  remains	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unclear	  and	  would	  be	  difficult	  to	  test	  from	  an	  ethical	  perspective,	  since	  the	  administration	  of	  
prophylactic	  antibiotics	  is	  widely	  considered	  as	  standard	  of	  care.	  In	  some	  trials,	  the	  incidence	  
of	  SSI	  in	  controls	  was	  very	  low	  and	  in	  others	  it	  was	  above	  20%,	  despite	  prophylactic	  
antibiotics.	  High	  FIO2	  appeared	  to	  be	  effective	  independent	  of	  the	  baseline	  risk	  of	  infection	  
(FIGURE	  2A).	  	  
The	  potentially	  beneficial	  effect	  of	  high	  FIO2	  on	  the	  incidence	  of	  PONV	  has	  been	  contentious	  
too.	  In	  2007,	  an	  international	  consensus	  panel	  did	  not	  recommend	  supplemental	  oxygen	  for	  
the	  prevention	  of	  PONV.74	  In	  2008,	  2	  meta-­‐analyses	  were	  addressing	  the	  potential	  benefit	  of	  
high	  FIO2	  on	  PONV;	  one	  concluded	  that	  supplemental	  oxygen	  reduced	  the	  incidence	  of	  
postoperative	  vomiting	  only,25	  the	  other	  was	  unable	  to	  identify	  any	  beneficial	  effect	  of	  high	  
FIO2.
23	  In	  our	  analysis,	  there	  was	  some	  evidence	  that	  high	  FIO2	  decreased	  the	  incidence	  of	  
both	  nausea	  and	  vomiting	  in	  patients	  receiving	  an	  inhalational	  anesthetic	  and	  no	  
prophylactic	  anti-­‐emetics.	  The	  baseline	  risk	  (i.e.	  the	  incidence	  of	  PONV	  in	  controls)	  was	  
increased	  in	  this	  context,	  and	  this	  may	  explain	  why	  high	  FIO2	  had	  more	  scope	  to	  show	  
antiemetic	  efficacy.	  However,	  absolute	  risk	  reductions	  suggested	  that	  about	  15	  patients	  
needed	  to	  receive	  high	  FIO2	  for	  one	  not	  to	  be	  nauseous	  or	  to	  vomit	  who	  would	  have	  done	  so	  
had	  they	  received	  normal	  FIO2.	  This	  degree	  of	  prophylactic	  antiemetic	  efficacy	  is	  weak,	  as	  
numbers-­‐needed-­‐to-­‐treat	  of	  3	  to	  5	  (absolute	  risk	  reduction,	  20	  to	  30%)	  may	  be	  expected	  
from	  an	  effective	  pharmacological	  antiemetic	  intervention	  in	  the	  surgical	  setting.74	  Also,	  
when	  analyzing	  the	  composite	  endpoint,	  PONV,	  no	  benefit	  was	  evident.	  	  
Nine	  trials	  reported	  on	  a	  large	  variety	  of	  pulmonary	  outcomes,	  including	  atelectasis,	  blood	  
gases,	  lung	  spirometry	  or	  postoperative	  SpO2.	  Results	  were	  difficult	  to	  compare	  as	  outcome	  
measures	  differed	  among	  studies.	  Dichotomous	  data	  on	  presence	  or	  absence	  of	  atelectasis	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could	  be	  combined	  from	  2	  small	  and	  2	  large	  trials.	  The	  result	  was	  clearly	  negative.	  Two	  
studies	  reported	  on	  postoperative	  PaO2/FIO2	  ratio.	  Both	  failed	  to	  show	  any	  detrimental	  
effect	  of	  high	  FIO2	  on	  postoperative	  gas	  exchange,	  despite	  using	  ventilation	  settings	  known	  
to	  acutely	  worsen	  pulmonary	  atelectasis11	  (i.e.	  administration	  of	  100%	  FIO2	  	  without	  positive	  
end-­‐expiratory	  pressure)	  in	  one	  trial.	  Additionally,	  in	  3	  studies	  reporting	  on	  surrogate	  
outcomes,	  there	  was	  no	  evidence	  of	  pulmonary	  harm	  when	  using	  a	  high	  FIO2	  regimen.	  Only	  
one	  trial,	  conducted	  in	  moderately	  obese	  patients,	  reported	  on	  a	  detrimental	  effect	  of	  high	  
FIO2	  on	  spirometric	  values	  postoperatively.	  	  
Our	  aim	  was	  to	  combine	  data	  from	  well-­‐controlled	  trials	  that	  had	  the	  scope	  to	  show	  
beneficial	  or	  harmful	  effects	  of	  high	  FIO2,	  if	  there	  were	  any.	  Our	  study	  differs	  twofold	  from	  
previously	  published	  similar	  meta-­‐analyses.20-­‐26	  Firstly,	  none	  of	  the	  previously	  published	  
meta-­‐analyses	  attempted	  to	  provide	  a	  complete	  picture	  of	  the	  potentially	  beneficial	  (SSI,	  
PONV)	  and	  harmful	  (pulmonary	  complications)	  effects	  of	  high	  FIO2.	  Secondly,	  our	  selection	  
criteria	  were	  stricter.	  For	  instance,	  we	  excluded	  studies	  where	  oxygen	  was	  delivered	  via	  a	  
facemask	  in	  awake	  patients	  undergoing	  regional	  anesthesia,75-­‐79	  or	  where	  supplemental	  
oxygen	  was	  provided	  to	  patients	  in	  the	  postoperative	  period	  only.80-­‐82	  Finally,	  to	  ensure	  that	  
the	  trials	  had	  the	  scope	  of	  showing	  an	  effect	  with	  high	  FIO2,	  we	  arbitrarily	  defined	  that,	  for	  
eligibility,	  the	  value	  of	  the	  normal	  FIO2	  had	  to	  be	  less	  than,	  or	  equal	  to,	  half	  of	  the	  high	  FIO2	  
value.	  
Included	  trials	  were	  performed	  in	  patients	  undergoing	  different	  surgical	  procedure,	  with	  a	  
variety	  of	  anesthetic	  regimens.	  Ideally,	  we	  would	  adjust	  these	  analyses	  for	  potential	  
confounding	  factors;	  in	  practice,	  this	  was	  not	  feasible	  as	  the	  number	  of	  analyzed	  trials	  was	  
limited.	  Critical	  analysis	  of	  all	  included	  trials	  suggested	  that	  they	  did	  not	  differ	  that	  much	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regarding	  potential	  confounders	  (table	  1-­‐3).	  Also,	  a	  certain	  degree	  of	  clinical	  heterogeneity	  
ensures	  wide	  applicability,	  or	  external	  validity,	  of	  the	  results	  of	  these	  analyses.	  However,	  
since	  all	  trials	  were	  performed	  in	  adults	  only,	  the	  results	  may	  not	  be	  applicable	  to	  children.	  
We	  did	  not	  include	  data	  from	  children,48-­‐50	  as	  there	  is	  an	  argument,	  at	  least	  when	  testing	  the	  
efficacy	  of	  an	  antiemetic	  intervention	  in	  the	  surgical	  setting,	  to	  distinguish	  between	  children	  
and	  adults.83	  Also,	  since	  trials	  reporting	  on	  SSI	  included	  mainly	  patients	  undergoing	  
abdominal	  surgery,	  extrapolation	  of	  our	  results	  to	  other	  types	  of	  surgery	  remains	  
speculative.	  Concerning	  antibiotic	  prophylaxis	  it	  has	  been	  argued	  that	  its	  efficacy	  in	  reducing	  
the	  risk	  of	  wound	  infection	  may	  be	  assumed	  for	  all	  types	  of	  surgery,	  even	  ones	  where	  no	  
clinical	  trial	  data	  exist.73	  	  
In	  conclusion,	  intraoperative	  high	  FIO2	  may	  be	  regarded	  as	  a	  supplemental	  strategy	  to	  
further	  decrease	  the	  risk	  of	  SSI	  in	  patients	  receiving	  prophylactic	  antibiotics.	  Indirect	  
comparison	  suggests	  that	  the	  degree	  of	  efficacy	  is	  similar	  to	  antibiotic	  prophylaxis	  in	  many	  
surgical	  settings.	  However,	  the	  efficacy	  of	  high	  FIO2	  per	  se,	  and	  in	  the	  absence	  of	  antibiotic	  
prophylaxis,	  remains	  unknown.	  High	  FIO2	  reduces	  the	  risk	  of	  PONV	  to	  some	  extent,	  although	  
mainly	  in	  patients	  undergoing	  inhalation	  anesthetics	  and	  without	  prophylactic	  anti-­‐emetics.	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